Trailing-twelve-month (TTM) revenue is $756.33 Million with a year-over-year growth of +17.17%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $178,513,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-28 |
| Q4 FY2025Period ended 2025-12-31 | $190,244,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-18 |
| Q1 FY2026Period ended 2026-03-31 | $180,189,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-28 |
| Q2 FY2026Period ended 2026-06-30 | $207,385,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-28 |
| TTM revenue | $756,331,000 |
Current P/S: $9,432,905,352 market capitalization ÷ $756,331,000 TTM revenue = 12.47x.
Market capitalization source: FMP quote. Quote observed 2026-09-11T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $207.38M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-12T00:15:55.943Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Contract and other Revenue | $48M | $48M | $88M | $86M | $84M | $80M |
| Product Revenue | $114M | $144M | $227M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Asia Other | $26M | $29M | $54M | N/A | N/A | N/A |
| CANADA | $1M | $119,000 | $220,000 |
$756.33M
$756.33 Million
+17.17%
vs. $645.50M a year ago (TTM)
+22.51%
5 Year compound annual growth rate
1 Year
+17.17%
3 Year
+17.33%
5 Year
+22.51%
10 Year
+9.70%
15 Year
+7.62%
20 Year
+7.61%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $707.63M | +$151.01M | +27.13% |
| 2024 | $556.62M | +$95.51M | +20.71% |
| 2023 | $461.12M | +$6.32M | +1.39% |
| 2022 | $454.79M | +$126.49M | +38.53% |
| 2021 | $328.30M | +$81.98M | +33.28% |
| 2020 |
TTM Growth
+17.17%
3-Year CAGR
+17.33%
5-Year CAGR
+22.51%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-12T00:15:55.943Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $247M |
| $348M |
| Royalty | $81M | $137M | $140M | $150M | $226M | $279M |
|---|
| N/A |
| N/A |
| Europe | $7M | $3M | $6M | N/A | N/A | N/A |
|---|
| JAPAN | $17M | $15M | $17M | N/A | N/A | N/A |
|---|
| KOREA, REPUBLIC OF | $4M | $6M | $7M | $152M | $198M | $329M |
|---|
| Other Countries | N/A | N/A | N/A | $79M | $90M | $90M |
|---|
| SINGAPORE | $28M | $40M | $57M | $53M | $67M | $164M |
|---|
| TAIWAN | N/A | N/A | $35M | N/A | N/A | N/A |
|---|
| TAIWAN, PROVINCE OF CHINA | $22M | $24M | N/A | N/A | N/A | N/A |
|---|
| UNITED STATES | $138M | $211M | $278M | $177M | $201M | $124M |
|---|
| $246.32M |
| +$22.30M |
| +9.95% |
| 2019 | $224.03M | ($7.17M) | (3.10%) |
| 2018 | $231.20M | ($161.90M) | (41.18%) |
| 2017 | $393.10M | +$56.50M | +16.79% |
| 2016 | $336.60M | +$40.32M | +13.61% |
